Are you aware of the potential risks associated with progestin use, particularly in contraceptive formulations? Recent studies have uncovered a concerning link between certain progestins and an increased risk of intracranial meningiomas, tumors that affect the membranes surrounding the brain. This briefing delves into the role of progesterone receptors, the benefits of subcutaneous DMPA administration, and significant epidemiological findings. As we explore these critical insights, you’ll discover how this information could impact your contraceptive choices and health. Join us in uncovering the vital connections between hormonal treatments and meningioma risk.